Mario Bargetzi

4.8k total citations
91 papers, 2.3k citations indexed

About

Mario Bargetzi is a scholar working on Hematology, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, Mario Bargetzi has authored 91 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 43 papers in Hematology, 34 papers in Oncology and 22 papers in Pathology and Forensic Medicine. Recurrent topics in Mario Bargetzi's work include Lymphoma Diagnosis and Treatment (20 papers), Hematopoietic Stem Cell Transplantation (19 papers) and Acute Myeloid Leukemia Research (16 papers). Mario Bargetzi is often cited by papers focused on Lymphoma Diagnosis and Treatment (20 papers), Hematopoietic Stem Cell Transplantation (19 papers) and Acute Myeloid Leukemia Research (16 papers). Mario Bargetzi collaborates with scholars based in Switzerland, United States and Belgium. Mario Bargetzi's co-authors include Urs Meyer, Frank J. Gonzalez, Toshifumi Aoyama, Aloïs Gratwohl, Raymonde Fonné‐Pfister, Marc Heizmann, Jakob Passweg, Martin Wernli, Luca Borradori and Peter Itin and has published in prestigious journals such as JAMA, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Mario Bargetzi

90 papers receiving 2.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mario Bargetzi Switzerland	26	813	747	686	425	324	91	2.3k
Eduardo Mysler United States	32	571 0.7×	1.0k 1.4×	421 0.6×	552 1.3×	448 1.4×	106	5.8k
Michael W. Schuster United States	29	1.1k 1.4×	1.5k 1.9×	398 0.6×	384 0.9×	1.3k 3.9×	94	3.2k
P M Wilkinson United Kingdom	31	1.0k 1.3×	332 0.4×	607 0.9×	287 0.7×	553 1.7×	87	3.4k
Judith A.M. Wessels Netherlands	23	338 0.4×	406 0.5×	104 0.2×	339 0.8×	446 1.4×	43	2.0k
Ingiäld Hafström Sweden	39	289 0.4×	731 1.0×	455 0.7×	296 0.7×	846 2.6×	111	4.8k
Shigeru Horita Japan	29	716 0.9×	219 0.3×	180 0.3×	106 0.2×	616 1.9×	123	2.7k
Manisha Bhutani United States	27	1.3k 1.6×	964 1.3×	294 0.4×	192 0.5×	1.0k 3.2×	144	2.8k
Deborah A. Bowen United States	28	384 0.5×	647 0.9×	1.3k 1.9×	1.4k 3.3×	627 1.9×	66	2.6k
Horst Schran United States	28	1.1k 1.4×	898 1.2×	72 0.1×	617 1.5×	626 1.9×	70	3.0k
Clara Chen United States	24	832 1.0×	227 0.3×	206 0.3×	90 0.2×	604 1.9×	101	2.6k

Countries citing papers authored by Mario Bargetzi

Since Specialization

Citations

This map shows the geographic impact of Mario Bargetzi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mario Bargetzi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mario Bargetzi more than expected).

Fields of papers citing papers by Mario Bargetzi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mario Bargetzi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mario Bargetzi. The network helps show where Mario Bargetzi may publish in the future.

Co-authorship network of co-authors of Mario Bargetzi

This figure shows the co-authorship network connecting the top 25 collaborators of Mario Bargetzi. A scholar is included among the top collaborators of Mario Bargetzi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mario Bargetzi. Mario Bargetzi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Bargetzi, Mario, et al.. (2022). Late effects of high-dose methotrexate treatment in childhood cancer survivors—a systematic review. BMC Cancer. 22(1). 267–267. 13 indexed citations

Zucca, Emanuele, Luciano Cascione, Sämi Schär, et al.. (2020). Prognostic models integrating quantitative parameters from baseline and interim positron emission computed tomography in patients with diffuse large B‐cell lymphoma: post‐hoc analysis from the SAKK38/07 clinical trial. Hematological Oncology. 38(5). 715–725. 16 indexed citations

Bond, Jonathan, Aurore Touzart, Stéphane Leprêtre, et al.. (2019). DNMT3A mutation is associated with increased age and adverse outcome in adult T-cell acute lymphoblastic leukemia. Haematologica. 104(8). 1617–1625. 35 indexed citations

Meier, Marc, Daniel Koch, Sebastian Haubitz, et al.. (2018). Biological pathways underlying the association of red cell distribution width and adverse clinical outcome: Results of a prospective cohort study. PLoS ONE. 13(1). e0191280–e0191280. 30 indexed citations

Baumgartner, Annic, Mario Bargetzi, Annika Bargetzi, et al.. (2016). Nutritional support practices in hematopoietic stem cell transplantation centers: A nationwide comparison. Nutrition. 35. 43–50. 37 indexed citations

Samaras, Panagiotis, Mario Bargetzi, Daniel Betticher, et al.. (2015). Current status and updated recommendations for diagnosis and treatment of plasma cell myeloma in Switzerland. Swiss Medical Weekly. 145(708). w14100–w14100. 4 indexed citations

Passweg, Jakob, Thomas Pabst, Sabine Blum, et al.. (2013). Azacytidine for acute myeloid leukemia in elderly or frail patients: a phase II trial (SAKK 30/07). Leukemia & lymphoma. 55(1). 87–91. 22 indexed citations

Bargetzi, Mario, et al.. (2010). Psychische Belastungen bei Krebspatienten und ihren Patienten im ersten Jahr nach Diagnoseerstellung. Distress among cancer patients and their partners in the first year after diagnosis. Bern Open Repository and Information System (University of Bern). 1 indexed citations

Taverna, Christian, Mario Bargetzi, Daniel Betticher, et al.. (2010). Integrating novel agents into multiple myeloma treatment – current status in Switzerland and treatment recommendations. Swiss Medical Weekly. 140(3738). w13054–w13054. 2 indexed citations

10.

Leupin, Nicolas, Jan C. Schuller, Max Solenthaler, et al.. (2010). Efficacy of rituximab and cladribine in patients with chronic lymphocytic leukemia and feasibility of stem cell mobilization: a prospective multicenter phase II trial (protocol SAKK 34/02). Leukemia & lymphoma. 51(4). 613–619. 6 indexed citations

11.

Krayenbuehl, Pierre‐Alexandre, Martin Hersberger, Kaspar Truninger, et al.. (2010). Toll-like receptor 4 gene polymorphism modulates phenotypic expression in patients with hereditary hemochromatosis. European Journal of Gastroenterology & Hepatology. 22(7). 835–841. 10 indexed citations

12.

Bargetzi, Mario, et al.. (2009). DV‐ICE, intensive induction and early transplantation for adult patients with acute lymphoblastic leukemia: a phase II study. European Journal Of Haematology. 83(6). 512–518. 2 indexed citations

13.

Röthlisberger, Benno, Marc Heizmann, Mario Bargetzi, & Andreas Huber. (2007). TRIB1 overexpression in acute myeloid leukemia. Cancer Genetics and Cytogenetics. 176(1). 58–60. 28 indexed citations

14.

Mühlematter, Dominique, V. Parlier, J Gmür, et al.. (2004). Systematic screening at diagnosis of −5/del(5)(q31), −7, or chromosome 8 aneuploidy by interphase fluorescence in situ hybridization in 110 acute myelocytic leukemia and high-risk myelodysplastic syndrome patients: concordances and discrepancies with conventional cytogenetics. Cancer Genetics and Cytogenetics. 152(1). 29–41. 31 indexed citations

15.

Heizmann, Marc, Peter Itin, Martin Wernli, Luca Borradori, & Mario Bargetzi. (2001). Successful treatment of paraneoplastic pemphigus in follicular NHL with rituximab: Report of a case and review of treatment for paraneoplastic pemphigus in NHL and CLL. American Journal of Hematology. 66(2). 142–144. 106 indexed citations

16.

Croockewit, Alexandra, Miguel H. Bronchud, Matti Aapro, et al.. (1997). A European perspective on haematopoietic growth factors in haemato-oncology: Report of an expert meeting of the EORTC. European Journal of Cancer. 33(11). 1732–1746. 12 indexed citations

17.

Bargetzi, Mario, Thomas Pabst, André Tichelli, et al.. (1996). Severe neutropenia in T-large granular lymphocyte leukemia corrected by intensive immunosuppression. Annals of Hematology. 73(3). 149–151. 8 indexed citations

18.

Bargetzi, Mario, André Tichelli, Agnès Devergie, et al.. (1995). Recombinant human interleukin‐3 in refractory severe aplastic anaemia: a phase I/II trial. British Journal of Haematology. 91(2). 306–312. 7 indexed citations

19.

Haefeli, Walter E., Mario Bargetzi, H. Fletcher Starnes, Terrence F. Blaschke, & Brian B. Hoffman. (1993). Evidence for Activation of the Sympathetic Nervous System by Recombinant Human Interleukin-1?? in Humans. Journal of Immunotherapy. 13(2). 136–140. 24 indexed citations

20.

Bargetzi, Mario, Toshifumi Aoyama, Frank J. Gonzalez, & Urs Meyer. (1989). Lidocaine metabolism in human liver microsomes by cytochrome P450IIIA4. Clinical Pharmacology & Therapeutics. 46(5). 521–527. 223 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact